Pharmafile Logo

TechnologyAdvice

Google’s Verily backs $300m European life sciences fund

The Medicxi fund for drug development firms also attracts support from Novartis

Can Cinderella save us?

Basilea bags $72m upfront from Pfizer for antifungal license

Pfizer will also pay $427m in future milestone payments for Cresemba

- PMLiVE

NICE rejects Pfizer’s antibody drug for leukaemia

Trial shows no survival benefit from Besponsa compared to current treatment

- PMLiVE

Hanover Health picks up a trio of new accounts

Adds Cambridge Medical Robotics, OMRON and Consultant Connect to its client roster

- PMLiVE

Ablynx appoints Markus Ewert as chief business officer

He will also join the Belgium-based biopharma firm's executive committee

Eli Lilly HQ

FDA fast-tracks Pfizer and Lilly’s tanezumab

The novel pain drug treats osteoarthritis and chronic low back pain

dengue fever mosquito

GSK cues up regulatory filings for relapsing malaria drug

60% of patients on tafenoquine combination remained relapse-free for six months

- PMLiVE

Gates Foundation agrees new polio funding deal

Expands its work with the Rotary Foundation and aims to raise up to $450m for the cause

- PMLiVE

The Creative Floor Healthcare Awards finalists announced

McCann Health London, Havas Lynx and Concentric are among those shortlisted

- PMLiVE

Growing Axon makes raft of new hires

The UK comms agency welcomes seven new starters across its med comms, PR and finance teams

- PMLiVE

Taking a lean and careful approach

Kunwar Shailubhai on why biotech is a roller coaster and how Tiziana Life Sciences is pursuing its mission to tackle unmet needs

- PMLiVE

Microsoft creates ‘Emma’ to aid with Parkinson’s

Prototype watch reduces uncontrollable shaking

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links